| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25778d19f5e786210ff0acdaea90a600
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e04d3093c3014d047d8676a9bcff33c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31a13d93e780ff97a800ac042a60d3d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14e5460fdf63b849f67b62f9162d10a8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6927
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce25ed50be9e4fb910766237b7f8a0fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd8e7b8a8d6f525319e966bc36191679 |
| publicationDate |
2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112015022925-B1 |
| titleOfInvention |
EXTENDED RELEASE PARTICLES OF PHENYLEPHRINE RESINATE, PHARMACEUTICAL FORMULATION, DRUG-RESIN COMPLEX AND ITS FORMATION METHOD |
| abstract |
SUMMARY Patent Invention "PHENYLEPHRINE RESIN PARTICLES AND THEIR USE IN PHARMACEUTICAL FORMULATIONS". The present disclosure describes phenylephrine particles suitable for solid, semi-solid or liquid dosage forms are disclosed. 1 A unit dose of approximately 84.2 mg of ER coated phenylephrine resinate particles is equivalent to a 20 mg dose of phenylephrine HCl. The unit dose of approximately 63.2 mg of ER coated phenylephrine resinate particles is equivalent to 15 mg of phenylephrine HCl, and this last unit dose was administered with 10 ml of liquid phenylephrine 2.5 mg/5 ml, for a total dose equivalent to 20 mg of phenylephrine HCl. 2 the extended release acetaminophen tablet formulation was the same commercially available granulation formulation in Tylenol(r) Arthritis. |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |